The UK has signed an agreement to secure 90 million doses of Covid-19 vaccines developed by Germany’s BioNTech and France’s Valneva. The deals, for which financial terms...
Germany’s BioNTech is confident it will be ready to seek regulatory approval for its mRNA-based Covid-19 vaccine by the end of this year, its co-founder and chief...
German biotech BioNTech, which is working on developing an mRNA vaccine against Covid-19 and has aligned itself with US pharma major Pfizer, this week raised $250 million...
To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to...
Paul-Ehrlich-Institut (PEI), Germany’s federal institute for vaccines and biomedicines, has given the go-ahead for Germany’s first clinical trial of a vaccine candidate...
08.01.2019
- French multinational pharmaceutical company Sanofi is investing €80 million in Germany’s BioNTech. At the same time, the two companies have agreed to extend their research...
05.11.2015
- French pharmaceutical producer Sanofi and German biotech firm BioNTech have agreed a multi-year exclusive collaboration and license agreement aimed at leveraging their respective...
